192 related articles for article (PubMed ID: 22366374)
21. Detection of hypoxia inducible factors and angiogenic growth factors during foetal endochondral and intramembranous ossification.
De Spiegelaere W; Cornillie P; Casteleyn C; Burvenich C; Van den Broeck W
Anat Histol Embryol; 2010 Aug; 39(4):376-84. PubMed ID: 20545637
[TBL] [Abstract][Full Text] [Related]
22. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.
Malec V; Gottschald OR; Li S; Rose F; Seeger W; Hänze J
Free Radic Biol Med; 2010 Jun; 48(12):1626-35. PubMed ID: 20347035
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
24. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome.
Comati A; Beck H; Halliday W; Snipes GJ; Plate KH; Acker T
J Neuropathol Exp Neurol; 2007 Jan; 66(1):86-97. PubMed ID: 17204940
[TBL] [Abstract][Full Text] [Related]
26. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
27. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.
Toffoli S; Roegiers A; Feron O; Van Steenbrugge M; Ninane N; Raes M; Michiels C
Angiogenesis; 2009; 12(1):47-67. PubMed ID: 19184477
[TBL] [Abstract][Full Text] [Related]
28. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
29. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of adaptive angiogenesis to tissue hypoxia.
Fong GH
Angiogenesis; 2008; 11(2):121-40. PubMed ID: 18327686
[TBL] [Abstract][Full Text] [Related]
31. HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.
Loboda A; Stachurska A; Florczyk U; Rudnicka D; Jazwa A; Wegrzyn J; Kozakowska M; Stalinska K; Poellinger L; Levonen AL; Yla-Herttuala S; Jozkowicz A; Dulak J
Antioxid Redox Signal; 2009 Jul; 11(7):1501-17. PubMed ID: 19254160
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.
Martin SK; Diamond P; Gronthos S; Peet DJ; Zannettino AC
Leukemia; 2011 Oct; 25(10):1533-42. PubMed ID: 21637285
[TBL] [Abstract][Full Text] [Related]
33. Regulation of hypoxia-inducible gene expression after HIF activation.
Suzuki N; Gradin K; Poellinger L; Yamamoto M
Exp Cell Res; 2017 Jul; 356(2):182-186. PubMed ID: 28286304
[TBL] [Abstract][Full Text] [Related]
34. HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development.
Dzhalilova DS; Makarova OV
Biochemistry (Mosc); 2021 Oct; 86(10):1163-1180. PubMed ID: 34903150
[TBL] [Abstract][Full Text] [Related]
35. HIF-1 and HIF-2 transcription factors--similar but not identical.
Loboda A; Jozkowicz A; Dulak J
Mol Cells; 2010 May; 29(5):435-42. PubMed ID: 20396958
[TBL] [Abstract][Full Text] [Related]
36. The role of hypoxia-inducible factors in tumorigenesis.
Rankin EB; Giaccia AJ
Cell Death Differ; 2008 Apr; 15(4):678-85. PubMed ID: 18259193
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
38. miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target.
Serocki M; Bartoszewska S; Janaszak-Jasiecka A; Ochocka RJ; Collawn JF; Bartoszewski R
Angiogenesis; 2018 May; 21(2):183-202. PubMed ID: 29383635
[TBL] [Abstract][Full Text] [Related]
39. Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells--the involvement of SP-1 and HIFs transcription factors.
Stachurska A; Kozakowska M; Jozkowicz A; Dulak J; Loboda A
Toxicol Lett; 2011 Jul; 204(2-3):118-26. PubMed ID: 21554934
[TBL] [Abstract][Full Text] [Related]
40. Role of oxygen and the HIF-pathway in polycystic kidney disease.
Buchholz B; Eckardt KU
Cell Signal; 2020 May; 69():109524. PubMed ID: 31904413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
